Ph.D., Chief Executive, Healx Ltd
Tim is a tech entrepreneur from the Cambridge Cluster (UK). He is passionate about the application of artificial intelligence for drug discovery. He is the co-founder and Chief Executive of Healx Ltd, a tech company focused on accelerating treatments for rare diseases. Passionate about patient impact, he is also the Founding Director of the Cambridge Rare Disease Network. He obtained his PhD from Cambridge University in Biophysical Neuroscience and his MEng in Biochemical-Engineering from Brussels University.
AI and Data Sciences Showcase: Healx
Healx identifies existing drugs that could treat rare diseases, offering a cost effective way to improve patient quality of life.
Translating 100 Rare Disease Treatments By 2025
From the 7,000 rare diseases, 95% are without approved treatment. Affecting 350M people world-wide. To address this huge therapeutic unmet need, Healnet was developed. The world’s leading AI-platform for rare diseases, enabling large-scale and hypothesis-free drug discovery.